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Background: Local epidemiology of Dengue is defined by the genetic diversity of the circulating Dengue virus
(DENV) strains. This important information is not available for the virus strains from most parts of the Indian
subcontinent. The present study focused on the genetic diversity of the serotype 3 DENV strains (DENV-3) from
India.
Results: A total of 22 DENV-3 strains identified by reverse-transcription PCR analysis of serum samples from 709
patients were studied. These samples were collected over a period of 4 years (2008–2011) from dengue fever
suspected patients from Kerala, a dengue endemic state in South India. Comparison of a 1740bp nucleotide sequence
of the viral Capsid-Pre-membrane-Envelope coding region of our strains and previously reported DENV-3 strains from
India, South Asia and South America revealed non-synonymous substitutions that were genotype III-specific as well as
sporadic. Evidence of positive selection was detected in the I81 amino acid residue of the envelope protein. Out of the
22 samples, three had I81A and 18 had I81V substitutions. In the phylogenetic analysis by maximum likelihood method
the strains from Kerala clustered in two different lineages (lineage III and IV) within genotype III clade of DENV-3 strains.
The ten strains that belonged to lineage IV had a signature amino acid substitution T219A in the envelope protein.
Interestingly, all these strains were found to be closely related to a Singapore strain GU370053 isolated in 2007.
Conclusions: Our study identifies for the first time the presence of lineage IV strains in the Indian subcontinent. Results
indicate the possibility of a recent exotic introduction and also a shift from the existing lineage III strains to lineage IV.
Lineage shifts in DENV-3 strains have been attributed to dramatic increase in disease severity in many parts of the
world. Hence the present observation could be significant in terms of the clinical severity of future dengue cases in the
region.
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Dengue, a mosquito vector transmitted viral infection,
has emerged as a major disease in recent times [1,2]. It
is prevalent in most of the tropical regions and affects
around 100 million people annually. Over the years,
there is an exponential increase in the cases of Dengue
fever (DF) or its severe forms, Dengue hemorrhagic
fever (DHF)/Dengue shock syndrome (DSS) across the* Correspondence: esreekumar@rgcb.res.in
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distribution, and reproduction in any mediumworld. This augmented incidence of dengue has been
attributed to increased air-travel, increased urbanization,
amplified mosquito population due to deterioration in
the public health infrastructure and changing climatic
conditions [2].
The Dengue virus (DENV) is a positive-stranded RNA
virus of the Flaviviridae family consisting of 4 serotypes
(DENV-1, 2, 3, and 4). Infection with one serotype
confers life-long protective immunity against a future in-
fection with the same serotype, but not against the other
three [2,3]. The ~11,000 base-pairs (bp) long viral gen-
ome consists of a small 5’non-translated region (5’NTR)ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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for the three structural and seven non-structural
proteins; and a 3’NTR of ~400 bp [2]. The Capsid (C),
Membrane (M) and Envelope (E) proteins form the
structural proteins and NS1, NS2A, NS2B, NS3, NS4A,
NS4B and NS5 proteins form the non-structural
proteins. The NS5 protein functions as the viral RNA-
dependent RNA polymerase that is responsible for repli-
cating the genome [4]. This protein has a low fidelity
during the viral genome replication contributing to the
genomic variability within the viral serotypes and a con-
stantly changing epidemiology of dengue. Identifying
such changes by genome analysis has become a major
tool in understanding dengue disease dynamics [5]. Pre-
vious studies have reported that almost all gene
segments of the virus are useful in generating informa-
tion on the viral evolution [6,7], though whole genome
analysis has gained more emphasis recently [8-10].
Dengue virus has been prevalent in the Indian subcon-
tinent for the last 50 years [11]. Like Southeast Asia, the
region has become hyperendemic to dengue with the cir-
culation of all the four serotypes [12]. Reflecting the global
trend, the disease incidence has been increasing with more
cases of DF and DHF over the years exhibiting a change in
disease epidemiology [13]. DENV-1 and DENV-3 have
been reported to be associated with increased incidence of
mortality in the country [14]. In the published literature,
genetic studies on the dengue virus from India have
mostly used strains from Northern and Western parts of
the subcontinent [7,10,14,15]. The southern region,
however, experiences regular incidences of small-scale
outbreaks of dengue [16-19], but there has been a very
limited study to understand the serotypes and genotypes
of the virus prevalent in this region. Since its first docu-
mentation in Kerala 44 years ago, dengue remained a low
profile disease in the state till its re-emergence in epidemic
form causing significant morbidity and mortality in 2003
[16]. As in other parts of the country, the dengue virus ac-
tivity in the state has gone up considerably in recent years
[11]. Our earlier studies have identified dengue outbreaks
in Kerala that had significant number of patients with con-
current infections involving multiple serotypes and also
the circulation of DENV-1 strains that are possibly
introduced from neighboring countries [18,19]. A progres-
sive molecular change in the viral strains, especially
DENV-1, was also observed [19].
The replacement of DENV-1 with DENV-3 in the den-
gue incidences in Northern India has been reported re-
cently indicating viral serotype swings in the region [20].
The serotype and genotype shifts occurring in circulat-
ing dengue viral strains in a locality are important causes
for enhanced severity of dengue outbreaks [13,21-23]. At
times, even the more subtle changes such as the ones at
the lineage level could alter the potential of the denguevirus to cause severe disease. This has been observed in
Sri Lankan DENV-3 strains [24-26]. In the present study,
we characterized DENV-3 strains circulating in Kerala
from 2008–2011 and compared the data with other
Indian and global strains to understand the genetic
variations. The information generated would be important
in deciphering dengue in the region at a molecular level.
Results
Clinical samples, viral nucleic acid and anti-dengue IgG
detection
In the four year period (2008–2011) of the study, acute-
phase serum samples from dengue-suspected patients
were collected from different parts of Kerala (Figure 1).
A total of 709 samples were analyzed by RT-PCR.
Among them, 162 samples were positive for viral nucleic
acid (22.84%), and by RT-PCR-based typing 56 were
DENV-1 (7.9%), 29 were DENV-2 (4%) and 32 were
DENV-3 (4.5%). DENV-4 strains could not be identified
in the clinical samples obtained during this period. Some
of these samples showed co-infection with multiple
serotypes [18]. Characterization of the DENV-1 strains
from these samples has been reported earlier [19]. In the
present study, we focused on the DENV-3 strains in the
samples that were obtained from single serotype
infections (n=22) (Table 1). Anti-dengue IgG ELISA
carried out in these samples to detect pre-existing im-
munity found 11 samples to be positive.
Detection of DENV3 infection of C6/36 cells by
immunofluorescence
Immunofluorescence analysis of infected cells indicated
presence of viral replication as evidenced by discrete
cytoplasmic fluorescence foci. Control cells did not show
any fluorescence signal in the analysis (Figure 2). Fur-
ther, the presence of virus was confirmed by RT-PCR
amplification of the RNA isolated from the supernatant
of infected cultures (data not shown).
Sequence analysis of the C-PrM-E region
A 1740 bp sequence (Figure 3; from position 291 to 2030
with respect to the NCBI DENV-3 reference sequence
NC_001475) was used in the analysis. The sequence
corresponds to the coding region for a partial Core pro-
tein, complete PrM region and partial envelope protein.
The region of the 22 sequences analyzed (Table 1) had an
average 94.4% nucleotide identity with the (NC_001475)
reference strain. Identity comparison with the sequences
of the closely related Indian strains GWL-25 (GenBank
Accession No.AY770511), ND-143 (FJ644564) and DEL-
72(GQ466079), which have been studied by whole genome
sequencing [10], two groups were detected - 11 sequences
with an average identity of 96.9% and remaining 11
sequences with an average identity of 99.1%. These two
Figure 1 Maps of (a) India and (b) Kerala. The sites of sample collection for the study are shown.
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pattern spanning across the 1740 bp region. Comparison
of the translated amino acid sequence of the region also
showed this delineation and revealed several substitutions
(Figure 3). Some of these substitutions, such as the M108I,
T112A in the capsid and I81A/V, S124P, H132Y, S164P,
A169T, K225E, T270N, K281E and L291T in the envelope
protein, were genotype specific substitutions present in all
the sequences compared (Figure 3). Three strains
(RGCB1200/11; RGCB1201/11 and RGCB1205/11) had
an L115F change in the capsid protein and ten strains had
T219A mutation in the envelope protein.
Phylogenetic analysis
The 1740 bp Capsid-Pre-membrane-Envelope (C-PrM-E)
coding region (Figure 4) of 158 sequences representing
four major genotypes of the DENV-3 (genotype I, II, III, V)
was used in the maximum likelihood analysis employing a
Tamurai-Nei substitution model with Gamma distributed
(G) rate among sites. A clear delineation of the four
genotypes was evident in the phylogram (Figure 4). All the
Indian strains used in the analysis, including the ones from
the present study, clustered within the genotype III. In
agreement with previous reports [10,14,20], five lineages
were decipherable within the genotype III clade, which had
a significant boot-strap support (>70%). The isolates from
Kerala were distributed between the lineage III and lineage
IV, whereas the three Indian strains used in the analysisclustered within the lineage III. The lineage III strains from
Kerala were closely related to the GWL-25 (AY770511),
ND143 (FJ644564) and DEL-72 (GQ466079) strains
from India used in the analysis. The lineage IV strains from
Kerala clustered with a recent Singapore isolate GU370053
collected in 2007. All the isolates obtained during 2011
confined to the lineage IV.
Recombination and selection pressure analysis
A data set comprising of 27 sequences [22 from the
current study, NC_001475 reference sequence, GWL-25
(AY770511), ND143 (FJ644564) DEL-72 (GQ466079)
and the Singapore isolate (GU370053)] was subjected to
recombination analysis and selection pressure analysis.
In the Datamonkey server used for the recombination
analysis, both the SBP and GARD methods failed to de-
tect any recombination events in the data set. Also, none
among the eight methods implemented through the re-
combination detection program RDP3Beta34 identified
recombination events. Nevertheless, in the selection
pressure analysis, four among the five methods used
identified various sites with statistically significant posi-
tive selection. The method SLAC failed to identify sites
with positive selection. However, only the codon for I81
in the envelope protein was identified to be under posi-
tive selection by more than one method. Three
programs- FEL (p-value 0.068), REL (Bayes factor 100.6)
and FUBAR (posterior probability 0.9572) - identified
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with the reference sequence whereas three strains-
RGCB350, RGCB429, RGCB632 had an alanine substitu-
tion, and the remaining 18 strains from the study
showed a valine substitution (Figure 3).
Discussion
Evolution through adaptive genetic changes plays a
major role in making dengue virus a successful pathogen
of the tropics [1,2]. It is fairly well established that such
acquired changes affect the dengue disease severity
[24,27]. Coupled with this, introduction of newer viral
strains by cross-border transmission causes unprece-
dented changes in dengue disease spectrum in a region
[13,28]. A keen monitoring of these events would be a
major requirement for successful dengue surveillance
and control programs.
Dengue virus has a uniform substitution rate across
the structural and non-structural proteins. This permits
the use of practically any of the genomic segments for
evolutionary analysis [6,7]. Here, we selected the C-PrM
-Envelope region. This region, being a structural protein,
accumulates adaptive mutations under selection pressure
for favoring infection of both human as well as mosquito
cells. It also represents a sequence stretch that hasTable 1 Details of samples used in the study
Sl no. Strain name Age /Sex Date of collectio
1 RGCB350/08 7/M 19-05-2008
2 RGCB353 /08 9/M 29-05-2008
3 RGCB429/08 20/M 28-11-2008
4 RGCB544/09 6Mnth/M 09-01-2009
5 RGCB632/09 30/M 25-04-2009
6 RGCB655/09 17/F 07-05-2009
7 RGCB804/10 5/F 16-03-2010
8 RGCB815/10 12/F 23-05-2010
9 RGCB825/10 22/M 04-06-2010
10 RGCB828/10 24/F 05-06-2010
11 RGCB830/10 33/M 08-06-2010
12 RGCB834/10 26/F 12-06-2010
13 RGCB837/10 42/F 14-06-2010
14 RGCB838/10 45/F 14-06-2010
15 RGCB915/10 28/M 21-12-2010
16 RGCB988/11 10/M 07-04-2011
17 RGCB1037/11 38/M 10-06-2011
18 RGCB1200/11 55/M 20-12-2011
19 RGCB1201/11 50/F 20-12-2011
20 RGCB1205/11 28/F 23-12-2011
21 RGCB1270/11 20/M 01-03-2011
22 RGCB1271/11 15/F 10-06-2011extensively been used in previous studies [7,18]. Com-
parative sequence analysis of the 22 strains and other
closely related strains revealed several mutations in the
Kerala strains. Most of these mutations were genotype
specific (Figure 3). Previous studies have shown that
many adaptive mutations in the dengue viral genome
map to the hinge region between the Domain I and II of
the envelope protein [29], which is thought to be
involved in the fusion with the cell membrane [30]. In
our samples, no substitutions were observed in this re-
gion. Two asparagine residues (N67 and N153) in the E
protein forming the N-linked glycosylation sites are
considered important in interacting with the putative
viral receptor [31,32]. Both of them were conserved
in all the strains studied. Among the amino acid
substitutions identified, the T219A mutation was a con-
sistent change that fell within the Domain II of the enve-
lope protein and was observed in 10 of the isolates
studied (Figure 3). This change was later on identified as
a signature substitution of the lineage IV strains as iden-
tified by the phylogenetic analysis (Figure 4).
DENV serotype 3 has five genotypes, and geographic
confinement and independent evolution of these
genotypes, especially the genotype I, II and III, have been























Figure 2 Immunofluorescence analysis of DENV-3 infected C6/36 mosquito cell line. Cells grown in 24-well cell culture plates were infected
with the indicated virus strains for three days. The viral replication was detected by immunostaining using anti-dengue virus polyclonal serum as
primary antibody and goat anti-rabbit IgG Alexa FluorW488 conjugated antibody as the secondary antibody. Uninfected cells and cells treated
only with the secondary antibody are shown as controls. The cytoplasmic fluorescent foci in the infected cells indicate the sites of virus
replication. Blue staining regions indicate the nuclei of the cells counterstained with DAPI . Scale bar represents 50 μm.
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strains [24], with the virus spreading from Sri Lanka to
the rest of the world [33]. Within DENV 3 genotype III,
five lineages have been designated [10]. The earlier geno-
type III DENV-3 strains from India isolated in 1984
belonged to the lineage V, which was later replaced with
lineage III strains that continues to circulate in the re-
gion [10,20]. This change was suggested as a cause for
the increased incidence of severe dengue cases post-
1990 [10]. In the present study we observe a shift
from lineage III to lineage IV (Figure 4). The clade
replacements leading to lineage shifts have resulted in
the emergence of viral strains causing more severe forms
of the disease in countries such as Sri Lanka [24] and
Singapore [26]. In the former study, it was hypothesized
that this distinction in disease severity may not be attrib-
utable to virus virulence alone, but could also be due to
the dengue immunity background of the population. A
pre-existing immunity to other serotypes can lead to
preferential neutralization of virus from one lineage and
at the same time, immune enhancement of infection of
other lineage [24]. Taking clue from this, we verified the
pre-existing immunity in the acute-phase samples
from our patients by checking the presence of anti-
dengue IgG and linked it with disease severity. Though
11 samples were IgG positive indicating secondary
infections, they all represented uncomplicated dengue
fever cases. So, it seems that the lineage shift per se has
not resulted in a dramatic change in disease profile.
DENV-1 and DENV-3 being the common serotypes in
Kerala, one possibility could be that the existing back-
ground immunity against DENV-1 does not support a
significant immune enhancement with these newer
strains of DENV-3. Moreover, since the lineage shift
seems to be of a recent occurrence, analysis of more
number of clinical cases over a longer period might be
essential to understand its true significance.The close similarity of the lineage IV DENV-3 strains
from the study to a Singapore strain is note-worthy.
Among the three sites chosen for sample collection, two
sites (Ernakulam and Thiruvananthapuram) have inter-
national airports, and all the lineage IV strains identified
were from these locations. Interestingly, these strains
were also genetically more divergent from this Singapore
strain in the phylogenetic analysis indicating that they
have undergone local evolution since their introduction
into the country. Our study thus indicates that there is
an inflow of DENV strains into the subcontinent along
with the outward spread of the strains as identified earl-
ier [33]. The presence of lineage III strains was confined
to the third sample collection site (Pathanapuram). This
place shared an interstate highway with the neighboring
state of Tamilnadu from where dengue outbreak involv-
ing the north Indian GWL-25 strains were being
reported [17].
As in many arboviruses, a strong purifying selection pre-
dominate the DENV evolution [12,34]. The occurrence of
adaptive mutations in viral strains are dictated by the need
for the virus to systematically replicate in the heterologous
host systems –the man and the mosquito–which in turn
has pointed to the incidence of convergent evolution via
positive selection [12]. This is exemplified by the evidence
of positive selection in the viral envelope protein residues
in previous studies [8,35-38]. Envelope is the major anti-
genic protein of the dengue virus that is subjected to con-
stant immune pressure. The I81 residue in the envelope
protein that is identified to be under positive selection in
our study (Figure 3) is located within the domain II of the
protein. This is a region important in conformational
change during low pH induced fusion of the virus with cell
membrane [39,40]. Also, this residue is located in the solv-
ent exposed loops in the tertiary structure of the envelope
protein [37]. The changes in the I81 site, thus, can have
functional consequences; however, the alanine / valine
Figure 3 (See legend on next page.)
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Figure 3 Comparative amino acid sequence analysis of the Capsid-PrM-Envelope region of DENV-3 strains. The amino acid sequences
derived from the nucleotide sequences of the capsid, pre-membrane and envelope coding region of the NCBI reference strain (NC_001475), viral
strains from Kerala and other closely related Indo-Pacific strains were aligned using Clustal W and compared. The domains and structural features
were located in the aligned sequences based on the previous report [31] and they are indicated in the figure. The signature amino acid
substitution T219A in lineage IV strains newly identified in the study is shown with an arrow.
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changes that might not affect protein secondary structure.
Conclusion
The present study strengthens the earlier reports on the
changing molecular pattern of dengue in India. Apart
from sporadic genetic changes in the viral strains the
study reveals genetic alterations resulting in lineage turn
over. The lineage turnover is considered as a common
phenomenon in dengue virus evolutionary dynamics,
and such events in a population are followed by period
of low prevalence of the new lineage strains [41].
These stochastic changes in one strain make way for the
strains of other serotypes to flourish, thereby altering
the disease epidemiology [41]. A temporal analysis of
the dengue disease profile in the region is imperative
to understand the long term sequel of the present
observations. Coupled with a complete genome analysis
of viral strains, this will enlighten our perception of the
progression of dengue in the sub-continent, and support
our efforts for its effective control.Materials and methods
Clinical samples, RT-PCR-based virus detection
and serology
An institution-based study involving three hospitals-the
SAT Hospital, Medical College, Thiruvananthapuram;
Community Health Centre, Pathanapuram, Kollam and
the General Hospital, Ernakulam- was carried out. The
first two hospitals are located in the two Southern most
districts of Kerala, approximately 75 km apart; whereas
the third one is located in central Kerala, approximately
250 km from Thiruvananthapuram (Figure 1). Acute-
phase blood samples from dengue suspected febrile
patients were obtained from the out-patient and in-patient
departments of these hospitals during the period 2008–
2011. Samples were obtained under informed consent,
and un-linked samples were processed as per the Institu-
tional Bio-safety Committee (IBSC) and Institutional
Human Ethics committee (IHEC) approved protocols.
Dengue viral RNA detection was done by an in-house RT-
PCR that amplifies a 654 bp Core-Pre-membrane (C-PrM)
coding region (nt from 132 to 783), as described previ-
ously [18,19]. Briefly, viral RNA was isolated from 140 μl
of patient serum using QiAmp Viral RNA isolation system
(Qiagen, Germany) and 5 μl of the RNA was RT-PCRamplified using single step RT-PCR kit (USB, Cleveland,
Ohio) using D1F and DencomR2 primers for initial virus
detection, or using D1F and nTS1/nTS2/nTS3/nDen4
primers (Table 2) for detection of the serotype. Presence
of anti-dengue IgG antibodies in the RT-PCR positive pa-
tient serum samples was detected using a commercial
ELISA kit (IVD Research Inc, Carlsbad, USA) as per the
protocol supplied along with the kit.Infection of C6/36 cells and DENV detection by
immunofluorescence
Dengue virus from RT-PCR positive samples was
isolated in C6/36 Aedes aegypti cell line [18]. The cells
were grown in L-15 medium with 10% Foetal Bovine
serum (FBS; Invitrogen) and 1× antibiotic-antimycotic
solution (Sigma) at 28°C. For infection, culture medium
was removed from confluent cultures in 25 cm2 flasks
(T-25) and an 1:10 dilution of patient serum in 1 ml
culture medium was added. Flasks were incubated for
2 hrs at 28°C. Subsequently, the cells were washed twice
with phosphate buffered saline (PBS; pH 7.4) and 5 ml
of L-15 medium (Invitrogen, Carlsbad) with 2% FBS and
1× antibiotic-antimycotic solution (Sigma) was added.
The cultures were incubated at 28°C for 5 days and the
virus containing supernatants were collected and stored
at −80°C in aliquots.
For immunofluorescence analysis, C6/36 cells were
cultured as described above on glass cover slips placed
in 24- well plates and infected as above with 200 μl of
the 1:10 diluted virus sample. Cells were incubated at
28°C for three days. Medium was carefully removed
from infected and uninfected control cells, and the cells
were fixed with 4 % paraformaldehyde for 15 min at 4°C
and washed 3 times with PBS. Permeabilization was
done with 0.2% Triton-X 100 for 10 min at room-
temperature and blocking was done with 8% normal
goat serum (Sigma) in PBS for 1 hour at 37°C in a moist
chamber. Primary antibody (Rabbit anti-dengue poly-
clonal serum; Catalogue No.GTX-29200; GeneTex;1:100
dilution) that can detect all the four serotypes of the
virus was added and was incubated at 37°C for 1 hour in
a moist-chamber. The cells were subsequently washed 3
times with PBS containing 0.1% Tween (PBS-T) and
1:500 dilution of goat anti-rabbit IgG Alexa FluorW488
conjugated antibody (Cat. No.A11008, Molecular Probes,
Invitrogen) was added and incubated for 30 min at room
Figure 4 (See legend on next page.)
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Figure 4 a. The Capsid-PrM-Envelope sequence region used in phylogeneticAnalysis. The positions are numbered with reference to the
NCBI strain NC_001475. b. Phylogenetic analysis using Maximum-Likelihood method. Nucleotide sequences of a 1740 bp partial C-PrM-E coding
region from 158 dengue serotype-3 virus representing the Indian, Asian and South American strains were used in the analysis. Analysis was
carried out with 1000 bootstrap replications employing a Tamurai-Nei substitution model with Gamma distributed (G) rate among sites. The scale
bar represents the number of nucleotide substitutions per site. Boot–strap values more than 70% are shown. GenBank accession number, place
and year of isolation are indicated. Sequences obtained in the study are shown with a filled triangle (‘▲’). To improve clarity, the clades
representing the related strains from Singapore, Puerto-Rico, Sri Lanka, Indonesia and Taiwan are shown compressed.
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stained with DAPI (1 μg/ml). The cover slips were care-
fully mounted over the microscopic slides and were
imaged using a Nikon TiS inverted fluorescent micro-
scope. Images were captured with a LucaR (Andor)
EMCCD camera using NIS elements software under
identical exposure (500 milliseconds) and gain settings
(6 units) for the infected cells as well as the controls. Cells
treated only with the secondary antibody served as back-
ground fluorescent staining control in the experiments.Nucleotide sequencing and analysis
RNA from virus isolates obtained after a single passage in
C6/36 cells was used for the RT-PCR amplification
and nucleotide sequencing. Viral RNA was isolated from
140 μl of the C6/36 culture supernatant as described
above, and was RT-PCR amplified using a high fidelity
RT-PCR system (Fidelitaq RT-PCR kit; USB, Cleveland,
Ohio) for amplifying a 2006 bp region spanning the C-
PrM-Envelope coding regions. The RT-PCR reaction
contained 10 pmol of the forward and reverse primers
(D1F & DV3EDIII R; Table 2) and 5 μl of viral RNA in a
50 μl reaction. The amplification conditions were as
described previously [18,19], except for an increased time
for the extension step (2min). The amplified product was
purified using the illustra GFX PCR purification Kit (GE
Healthcare, Buckinghamshire, UK). Both strands of the
amplicon were then sequenced with specific forward and
reverse primers (Table 2) using the Big-dye Terminator
Cycle sequencing kit in an ABI 3730 Genetic Analyzer
automated DNA sequencer (PE Applied Biosystems,
Foster City, CA). The comparative analysis of nucleotideTable 2 Primers used in the study
Primer
name
Sequence (5’→ 3’) Location







DV3EDIIIR AAGCTTCTACTACTCGAACATCTTCCCAAT 2137-2120and amino acid sequences of Indian as well as closely
related Indo-Pacific isolates was carried out using the
Clustal W function of the Bio-Edit 6.0.7software [42].
Phylogenetic analysis
MEGA5.5 program [43] was used for phylogenetic ana-
lysis. The sequences used in the previous studies
employing Indian strains [10] and the Indo-Pacific
strains [8,33], and also the unpublished sequences of
DENV-3 strains from the South and South East Asia
and from the South America accessible from National
Center for Biotechnology Information (NCBI) GenBank
database (http://www.ncbi.nlm.nih.gov) were used
as the dataset. The sequences were initially aligned
by Clustal W [42] and the nucleotide substitution
model for each data set was identified by the Model
(ML) function in the MEGA5.5 program. Subsequently,
maximum-likelihood analysis with 1000 boot-strap
replications was carried out for the sequence data set
using the identified substitution model.Recombination and selection pressure analysis
To detect recombination and identify recombination
break points in the data alignment, two methods- SBP
(Single Break Point recombination) and GARD (Genetic
Algorithms for Recombination Detection) [44]- were ini-
tially carried out using the online adaptive evolution server
http://www.datamonkey.org/ [45]. Subsequently, a second
program, RDP3Beta34 [46], was also used to reconfirm
the results obtained. Default setting of this program for
linear sequences was executed for implementing RDP,
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PHYLPRO [53] in the analysis.
Selection pressure analysis was carried out in the ser-
ver http://www.datamonkey.org/ [45]. For identifying the
residues with positive selection based on the ratio of
non-synonymous to synonymous substitutions (dN/dS
ratio), three different codon-based likelihood methods-
Single Likelihood Ancestor counting (SLAC), Fixed
Effects Likelihood (FEL) and Random Effects Likelihood
(REL) - executed by the server were employed. The esti-
mation of site-by-site substitution rates by the SLAC
and FEL employs conservative methods whereas a less
conservative method is used in the REL, which is best
suited for small data sets with low sequence divergence.
In addition, two newly introduced algorithms in the
Datamonkey server -FUBAR and Mixed effects model
evolution (MEME) were also executed to analyze the
data set. Default parameters that used a Neighbour
Joining tree and a significance setting of P-value/Bayes
factor <0.1 for SLAC, FEL and MEME; a Bayes Factor of
50 for REL; and a posterior probability of 0.9 for
FUBAR, were set in the analysis.
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